Literature DB >> 21686698

A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy.

Maria Muglia1, Giovanni Vazza, Alessandra Patitucci, Micaela Milani, Davide Pareyson, Franco Taroni, Aldo Quattrone, Maria Luisa Mostacciuolo.   

Abstract

Charcot-Marie-Tooth (CMT) disease is the most common hereditary neuropathy. CMT falls into two main forms: the demyelinating CMT type 1 with decreased nerve conduction velocities and the axonal CMT type 2. CMT2 is further subtyped by linkage analysis into >10 loci, with eight genes identified.Recently, mutations in the mitochondrial fusion protein 2 (MFN2) gene were reported in families with CMT2A1 and additional mutations have been detected in other studies, bringing to 42 the total number of different MFN2 mutations described thus far.2(-)4In the current study, we report a novel MFN2 mutation shared by two apparently unrelated CMT2 families originating from the same area in Southern Italy.

Entities:  

Year:  2009        PMID: 21686698      PMCID: PMC3029558          DOI: 10.1136/bcr.08.2008.0652

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

2.  Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.

Authors:  Victoria H Lawson; Brad V Graham; Kevin M Flanigan
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

3.  Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.

Authors:  K W Chung; S B Kim; K D Park; K G Choi; J H Lee; H W Eun; J S Suh; J H Hwang; W K Kim; B C Seo; S H Kim; I H Son; S M Kim; I N Sunwoo; B O Choi
Journal:  Brain       Date:  2006-07-10       Impact factor: 13.501

4.  MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2.

Authors:  Kristien Verhoeven; Kristl G Claeys; Stephan Züchner; J Michael Schröder; Joachim Weis; Chantal Ceuterick; Albena Jordanova; Eva Nelis; Els De Vriendt; Matthias Van Hul; Pavel Seeman; Radim Mazanec; Gulam Mustafa Saifi; Kinga Szigeti; Pedro Mancias; Ian J Butler; Andrzej Kochanski; Barbara Ryniewicz; Jan De Bleecker; Peter Van den Bergh; Christine Verellen; Rudy Van Coster; Nathalie Goemans; Michaela Auer-Grumbach; Wim Robberecht; Vedrana Milic Rasic; Yoram Nevo; Ivajlo Tournev; Velina Guergueltcheva; Filip Roelens; Peter Vieregge; Paolo Vinci; Maria Teresa Moreno; H-J Christen; Michael E Shy; James R Lupski; Jeffery M Vance; Peter De Jonghe; Vincent Timmerman
Journal:  Brain       Date:  2006-05-19       Impact factor: 13.501

5.  Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).

Authors:  Kathrin Engelfried; Matthias Vorgerd; Michaela Hagedorn; Gerhard Haas; Jürgen Gilles; Jörg T Epplen; Moritz Meins
Journal:  BMC Med Genet       Date:  2006-06-08       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.